Your widget preview
RSS feeds
Be the first to announce the news!!
|
PEGINTRON(R) Receives A Recommendation For Approval From FDA Advisory Committee For A New Application In Melanoma Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced that the FDA Oncologic Drug Advisory Committee voted in favor of recommending approval of PEGINTRON® as a treatment in addition to surgery in patients with metastatic melanoma. The product is currently being marketed, manufactured and developed by Schering-Plough. Medical News TodayMD Biosciences Expansion To Increase Capacity In Pre-Clinical Drug Discovery Services And Products For Inflammatory And Neurological Diseases MD Biosciences (MDB), a contract research organization offering pre-clinical services and products in support of drug discovery for inflammatory and neurological diseases, relocated its U.S. office from 1000 Westgate Dr, St Paul, MN to 2575 University Ave W, St Paul, MN on October 3, 2009. The new location equips MD Biosciences with more lab space, allowing for increased capacity for in vitro services and product development and manufacturing to increase product offering. Medical News TodayCourt challenge to tobacco-advertising ban The maker of Marlboro cigarettes today mounted a legal challenge to overturn the country’s ban on advertising tobacco products in shops.Philip Morris Ltd (PML) and Donegal retailer, Maurice Timony, ... Join TogetherPriority Health Expands Medicare Advantage For 2010 Priority Health announced today it is expanding both its Medicare Advantage service area and the Medicare Advantage products it will offer effective Jan. 1, 2010. Residents in 31 Michigan counties will be able to choose Priority Health Medicare Advantage coverage in 2010, up from 23 counties in 2009. Medical News TodayMedline Signs Exclusive Agreement to Distribute Polymedic Regional Anesthesia Medical Devices and Single-Use ProductsMarket Wire Top-15 Pharmaceutical Company Engages SK&A for Healthcare Market Research Services IRVINE, CA--(Marketwire - October 6, 2009) - With more than 70,000 phone calls made targeting 45,000 multispecialty office-based physician sites throughout the U.S., SK&A Information Services, a leading provider of healthcare information solutions and research, today announced the completion of its largest market research project in its 27-year history. The two and a half month project provided intelligence for the client's market research, marketing and sales to optimize targeting and engagement strategies for a new product launch. SK&A Research Associates identified decision makers and determined office practices and procedures for appointment setting, billing and coding, therapies, lab referrals, pharmacy authorizations, and more. When the project concluded, SK&A imported data to the client's in-house databases, including market research and sales force automation systems for immediate access. Market WireEnWave Files Canadian nutraREV(TM) Patent VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 6, 2009) - EnWave Corporation (TSX VENTURE:ENW) ('EnWave', or the 'Company') has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ('PCT') patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ('IPRP') is forthcoming. The PCT process allows inventors to obtain patent priority in more than 140 countries at the same time, thereby saving considerable time and deferring the cost of individual national filings for 30 months. EnWave has now filed a Canadian national patent application for the nutraREVTM equipment with a request for expedited review in order to receive an issued patent as quickly as possible. The Company believes a Canadian patent on this technology will further reinforc Market WireLetter to Shareholders of XTend Medical (XMDC) From the CEO Regarding the Upcoming Merger With BioHarp, Korea SUN VALLEY, CA--(Marketwire - October 6, 2009) - XTend Medical (PINKSHEETS: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following letter from the CEO, Mr. Paul D. Lisenby, regarding the upcoming merger with BioHarp, Korea and other corporate progress. 'To all XTend shareholders, I want to bring everyone up to date on the upcoming merger with BioHarp, Korea, and to share some insight into the future of the company. As you are aware from our most recent press release, we've decided to merge our company with BioHarp, Korea in order to have one of the most intriguing and cutting-edge medical devices to hit the healthcare industry in decades. The potential for this device to change the way patient diagnostics are currently being done is tremendous. The BioHarp is a non-invasive scanning device that can be used by a trained profession Market WireGlobeImmune Announces Late-Breaker Presentation of GI-5005 Treatment Response Data at AASLD 2009 Meeting LOUISVILLE, CO--(Marketwire - October 6, 2009) - GlobeImmune Inc. today announced that a late breaking abstract related to GI-5005, its investigational hepatitis C virus (HCV) product candidate, has been accepted for presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place Oct. 31 through Nov. 4, 2009, in Boston, Mass. The abstract, titled 'GI-5005 Therapeutic Vaccine Plus PEG-IFN/Ribavirin Improves End of Treatment Response at 48 Weeks Versus PEG-IFN/Ribavirin in Naïve Genotype 1 Chronic HCV Patients,' is published online at the AASLD website (www.aasld.org). Market WireRetailer challenges tobacco law A Donegal retailer is to launch a legal bid to overturn the ban on the display of tobacco products in Irish shops.The ban on displaying tobacco products in shops in the Republic of Ireland came into e... Big News Network1 2 |
Updating news archive  |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Popular search keywords in health:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available news archives.
How does Feedzilla work?
Feedzilla is a news aggregator which categorizes news stories by topic. It is a platform where webmasters and bloggers can find an unmatched selection of easy to use, automatically updating and professional news widgets for their sites. Feedzilla supports the building of widgets in various formats, as well as allowing the addition of news widgets to different blogging platforms and social networks.
Feedzilla manually aggregates news summaries found in RSS feeds, and redistributes them in either RSS format or as a news widget. Content is collected 24 hours a day, 7 days a week from an ever-growing list of providers.
Hot keywords
accused plot • accused seeking • acting attorney • administration plans • alive scottish • already fretting • american shopping • attack mall • attack malls • big pay • black barbies • board building • building downtown • bulatci attempted • charged providing • chinas gdp • companies already • companies received • compensation board • compensation highest • de janeiro • death rcmp • downtown edmonton • draft deal • edmonton surrendered • ends surrender • england man • failed terrorist • firms obama • found body • fretting holiday • friends tried • gunman held • halloween offers • held hostages • heroin trade • hn vaccine • holiday shopping • hostages edmonton • hostages workers • iran nuclear • kill kidnap • kill politicians • kill prominent • lockerbie bomber • maim injure • mall attack • malls authorities • man charged • manslaughter shooting • mass man • massachusetts man • material support • missile defense • mountie murder • muslim school • north korea • nuclear watchdog • nuclear weapons • obama administration • offers hope • officer hay • olympics rio • order companies • overseas kill • paid executives • pay cuts • percent quarter • planning trips • plea rejected • plead guilty • plot attack • police looking • politicians randomly • president joe • purple lady • recession companies • rife favoritism • river nwt • season halloween • seeking training • shoot people • shopping mall • shopping season • surrender gunman • swine flu • tarek mehanna • terror plot • terror suspect • then plotted • too westernized • training camps • training taliban • trial emrah • workers compensation •
News poll
Press release
9th of September 2009 - Interview of Feedzilla's founder at the IFA in Berlin. [More]
Testimonials
I appreciate your newsfeeds for websites and taking the time to help me use more effectively.
Gerry Peters
© 2009 Butterfly Effect SA